07:40 AM EDT, 07/07/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Monday that it has appointed Babar Ghias as chief financial officer and head of corporate development.
Ghias joins the company from AvenCell Therapeutics, where he served as CFO since 2022.